PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 111 filers reported holding PLIANT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,164,919 | -5.3% | 67,181 | -1.0% | 0.00% | 0.0% |
| Q2 2023 | $1,229,659 | +13.2% | 67,862 | +66.1% | 0.00% | 0.0% |
| Q1 2023 | $1,086,690 | +102.4% | 40,853 | +42.6% | 0.00% | – |
| Q4 2022 | $536,987 | -9.1% | 28,643 | +0.7% | 0.00% | – |
| Q3 2022 | $590,497 | +645.5% | 28,440 | +151.7% | 0.00% | – |
| Q1 2022 | $79,213 | -56.5% | 11,300 | -16.3% | 0.00% | – |
| Q4 2021 | $182,000 | -16.5% | 13,497 | +4.4% | 0.00% | – |
| Q3 2021 | $218,000 | -45.1% | 12,934 | -5.1% | 0.00% | – |
| Q2 2021 | $397,000 | -24.4% | 13,626 | +2.1% | 0.00% | – |
| Q1 2021 | $525,000 | – | 13,349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |